| Overview |
| bsm-90349R |
| Smad2 Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human smad2 |
| 50-100/467 |
| Monoclonal |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 4087 |
| Q15796 |
| JV18-1; MADR2; MADH2; Mothers Against Decapentaplegic Homolog 2; MAD Homolog 2; HMAD-2; HSMAD2; MAD Mothers Against Decapentaplegic Homolog 2 (Drosophila); SMAD Mothers Against DPP Homolog 2 (Drosophila); SMAD Mothers Against DPP Homolog 2; Sma- And Mad-Related Protein 2; Mothers Against DPP Homolog 2; Mother Against DPP Homolog 2; Mad-Related Protein 2; SMAD 2; CHTD8; Smad2; JV18; LDS6 |
| Cell Line: HT-1080 Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |
Powered by Bioz